Thomas W. Martens

1.6k total citations
30 papers, 355 citations indexed

About

Thomas W. Martens is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Thomas W. Martens has authored 30 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Genetics. Recurrent topics in Thomas W. Martens's work include Diabetes Management and Research (19 papers), Diabetes Management and Education (7 papers) and Diabetes and associated disorders (6 papers). Thomas W. Martens is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Management and Education (7 papers) and Diabetes and associated disorders (6 papers). Thomas W. Martens collaborates with scholars based in United States, Germany and Belgium. Thomas W. Martens's co-authors include Richard M. Bergenstal, Anders L. Carlson, Amy Criego, Gregg D. Simonson, Mark A. Longer, M. Veillard, Joseph R. Robinson, Mary L. Johnson, Meinhard Simon and Thorsten Brinkhoff and has published in prestigious journals such as JAMA, Diabetes and Journal of Controlled Release.

In The Last Decade

Thomas W. Martens

26 papers receiving 337 citations

Peers

Countries citing papers authored by Thomas W. Martens

Since Specialization

Citations

This map shows the geographic impact of Thomas W. Martens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Martens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Martens more than expected).

Fields of papers citing papers by Thomas W. Martens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Martens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Martens. The network helps show where Thomas W. Martens may publish in the future.

Co-authorship network of co-authors of Thomas W. Martens

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Martens. A scholar is included among the top collaborators of Thomas W. Martens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Martens. Thomas W. Martens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study 2025 ·Diabetologia ·Dominic Ehrmann, Heidi Krause‐Steinrauf, Diane Uschner, (unknown), Claire J. Hoogendoorn, (unknown), (unknown), Valerie Arends, (unknown), W. Timothy Garvey, Thomas W. Martens, Holly Willis, Andrea Cherrington, Jeffrey S. Gonzalez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Continuous Glucose Monitoring 2025 ·JAMA ·Richard M. Bergenstal, Thomas W. Martens, Roy W. Beck	0
3	A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin 2025 ·Diabetes Technology & Therapeutics ·Thomas W. Martens, Holly Willis, Richard M. Bergenstal, Davida Kruger, Esra Karslioglu French, Devin Steenkamp	2
4	Continuous glucose monitoring versus fasting blood glucose basal insulin titration: a retrospective analysis 2025 ·Diabetes & Metabolic Syndrome Clinical Research & Reviews ·Thomas W. Martens, Jennal Johnson, Michelle L. Katz, Michael Davidson, Karen Schneck, Jie Xue, Xinyue Chang, Eyal Dassau	0
5	Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis 2025 ·Journal of Diabetes Science and Technology ·Raveendhara R. Bannuru, Natalie J. Bellini, Richard M. Bergenstal, Elizabeth A. Beverly, Elena A. Christofides, Daniel J. Cox, Nicole Ehrhardt, (unknown), Amy Hess Fischl, David Kerr, Otis W. Kirksey, Ka Hei Karen Lau, Thomas W. Martens, Meredith Noble, (unknown), Viral N. Shah, Holly Willis, Nuha A. ElSayed	0
6	Using continuous glucose monitoring data in daily clinical practice 2024 ·Cleveland Clinic Journal of Medicine ·Thomas W. Martens, Gregg D. Simonson, Richard M. Bergenstal	4
7	356-OR: A Randomized Controlled Trial Using Continuous Glucose Monitoring (CGM) to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes Not Taking Insulin 2024 ·Diabetes ·Thomas W. Martens, Holly Willis, Davida Kruger, Esra Karslioglu French, Devin Steenkamp	1
8	Primary Care and Diabetes Technologies and Treatments 2024 ·Diabetes Technology & Therapeutics ·Thomas W. Martens, Gregg D. Simonson, Anders L. Carlson, Richard M. Bergenstal	3
9	Roadmap to the Effective Use of Continuous Glucose Monitoring in Primary Care 2023 ·Diabetes Spectrum ·Thomas W. Martens	5
10	Primary Care and Diabetes Technologies and Treatments 2023 ·Diabetes Technology & Therapeutics ·Gregg D. Simonson, Thomas W. Martens, Anders L. Carlson, Richard M. Bergenstal	1
11	How use of continuous glucose monitoring can address therapeutic inertia in primary care 2022 ·Postgraduate Medicine ·Thomas W. Martens, Christopher G. Parkin	10
12	Primary Care and Diabetes Technologies and Treatments 2021 ·Diabetes Technology & Therapeutics ·Thomas W. Martens, Gregg D. Simonson, Anders L. Carlson, Richard M. Bergenstal	2
13	Trial of a New Diabetes Education Model: Closing the Gap in Health Disparity for People with Diabetes 2021 ·Journal of Diabetes Science and Technology ·Thomas W. Martens, (unknown), Elizabeth A. Johnson, (unknown), (unknown), Richard M. Bergenstal, Anders L. Carlson, (unknown)	5
14	HbA1c 2019 ·Endocrinology and Metabolism Clinics of North America ·Anders L. Carlson, Amy Criego, Thomas W. Martens, Richard M. Bergenstal	23
15	1280-P: Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care 2019 ·Diabetes ·Thomas W. Martens, Richard M. Bergenstal, Mary L. Johnson, (unknown), Gregg D. Simonson	2
16	Long-term follow-up and quality of life in patients with intracranial germinoma 2014 ·Neurosurgical Review ·Thomas W. Martens, Roman Rotermund, Christine zu Eulenburg, Manfred Westphal, Jörg Flitsch	14
17	Skeletal spread of an anaplastic astrocytoma (WHO grade III) and preservation of histopathological properties within metastases 2012 ·Clinical Neurology and Neurosurgery ·Thomas W. Martens, Jakob Matschke, Carolin Müller, Sabine Riethdorf, Stefan Balabanov, Manfred Westphal, Oliver Heese	8
18	Intracranial Aneurysms in Childhood: Report of 8 Cases and Review of the Literature 2009 ·PubMed ·Jan Regelsberger, Oliver Heese, Thomas W. Martens, Thorsten Ries, Paul Kunkel, M. Westphal	10
19	Effects of phytoplankton bloom in a coastal ecosystem on the composition of bacterial communities 2007 ·Aquatic Microbial Ecology ·(unknown), (unknown), Thomas W. Martens, (unknown), Meinhard Simon, Thorsten Brinkhoff	66
20	Association of decreased intercellular communication with the immortal but not the tumorigenic phenotype in human mammary epithelial cells. 1989 ·PubMed ·Sandra R. Eldridge, Thomas W. Martens, C A Sattler, Michael N. Gould	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact